Provincial Drug Coordination and a Uniform Denial Across Canada
Maple Ridge Retail has 900 employees in Ontario, Alberta, and Quebec. Its group benefit plan, insured by a carrier, has a $10,000 annual drug maximum, a prior-authorization requirement for biologics, and an out-of-country emergency benefit. An Ontario employee with rheumatoid arthritis needs a biologic costing $38,000 per year. The provincial drug program may cover some cost after a deductible, but the private plan is first payer. The carrier denies the drug because the plan maximum is exhausted and the drug is not on the provincial formulary without a special authorization. The employee asks the employer to increase the maximum or approve an exception. A Quebec employee has a similar request, but Quebec's rules require private coverage to coordinate with RAMQ. The employer's HR team wants to apply the same denial across all provinces to control costs.
1. Can the employer apply a uniform denial across Ontario, Alberta, and Quebec? Analyze plan terms, provincial coordination, and human rights.
Read the worked answer
A single national denial is not appropriate. Group benefit plans are governed by the plan text, the insurance contract, and provincial rules. In Ontario, the private plan is generally first payer, but the employee may have access to the provincial Trillium Drug Program or manufacturer support after the private maximum; the employer should not assume the provincial plan will fill the gap automatically. In Alberta, the provincial drug program and private plan coordination differ. In Quebec, the private plan must provide coverage at least equivalent to the RAMQ plan, and the employer cannot simply apply an Ontario-style maximum to Quebec employees if it would violate Quebec rules. The employer should also consider human rights legislation, which may require accommodation for a disability-related need, and the plan's prior-authorization and exception process. The carrier's denial should be reviewed against the plan wording and provincial coordination rules before any uniform position is adopted.
2. What options are available to address the Ontario employee's $38,000 drug cost?
Read the worked answer
For the Ontario employee, the employer should ask the carrier to review an exception based on medical necessity and the plan's prior-authorization criteria. If the plan maximum is the barrier, the employer can consider a prospective plan amendment increasing the maximum for specialty drugs, a separate specialty-drug fund, or a case-by-case exception policy. The employer should also explore manufacturer patient-support programs, the provincial catastrophic drug program, and coordination of benefits. Any exception should be documented and applied consistently to avoid discrimination claims. The employer should not promise coverage it cannot fund; if it cannot amend the plan, it should explain the appeal and external review rights.
3. What privacy and communication issues arise?
Read the worked answer
The employer should limit collection and disclosure of health information to what is necessary for the accommodation or claims review. In Ontario, PHIPA governs health information; federally, PIPEDA applies to commercial activity; Quebec has its own privacy rules. The carrier and vendor should have appropriate safeguards, and individual results should not be shared with managers or the safety team. Communication should be respectful and should not identify the employee. The employer should obtain consent where required and tell the employee how to appeal.